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Amelioration of lead-induced
hepatotoxicity by Allium sativum
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Lead is a bluegray and highly toxic divalent metal that occurs naturally in the earth’s crust and is spread
throughout the environment by various human activities. The efficacy of garlic (Allium sativum) to reduce
hepatotoxicity induced by lead nitrate was evaluated experimentally in male mice. Oral treatment with lead
nitrate at a dose of 50 mg/kg body weight daily for 40 days (1/45 of LD50) induced a significant increase in the
levels of hepatic aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, acid phospha-
tase, cholesterol, lipid peroxidation, and lead nitrate. In parallel, hepatic protein levels in lead-exposed mice
were significantly depleted. Lead nitrate exposure also produced detrimental effects on the redox status of the
liver indicated by a significant decline in the levels of liver antioxidants such as superoxide dismutase, catalase,
and glutathione. After exposure to lead nitrate (50 mg/kg body weight for 10 days), the animals received
aqueous garlic extract (250 mg/kg body weight and 500 mg/kg body weight) and ethanolic garlic extract (100
mg/kg body weight and 250 mg/kg body weight), and partially restored the deranged parameters significantly.
Histological examination of the liver also revealed pathophysiological changes in lead nitrate-exposed group
and treatment with garlic improved liver histology. Our data suggest that garlic is a phytoantioxidant that can
counteract the deleterious effects of lead nitrate.
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M
any metals play important roles in the func-
tioning of enzymes, cell-signaling processes,
and gene regulation. Lead is not known to
have any biological role. Increasing concern has been
expressed about the rapidly rising level of chemicals in the
environment, particularly lead, which has well-known
hazardous effects. In India, the range of sources of lead
exposure is extensive and yet not well understood. This
ubiquitous environmental pollutant enters the atmo-
sphere from production of coal, oil, iron, steel, and
batteries, as well as from smelters, solid waste, and
tobacco smoke. Lead can disrupt biological systems by
altering the molecular interactions, cell signaling, and
ultimately cellular function. The toxic effect of lead
nitrate is well documented in mammals, in which it leads
to a broad range of physiological, biochemical, and
behavioral dysfunctions (1). Lead exposure occurs mainly
through the respiratory and gastrointestinal systems.
Liver is a frequent target for many toxicants (2). Autopsy
studies of lead-exposed humans indicate that among soft
tissue, liver is the largest repository (33%) of lead,
followed by kidney. Lead-induced hepatic damage is
mostly rooted in lipid peroxidation (LPO) and distur-
bance of the prooxidantantioxidant balance by genera-
tion of reactive oxygen species (ROS) (3, 4).
The currently approved treatment for lead intoxication
is to give chelating agents, such as meso-2,3-dimercapto-
succinic acid (DMSA) and monoisoamyl DMSA
(MiADMSA), which form an insoluble complex with
lead and shield it from biological targets, thereby redu-
cing its toxicity (5).
However, these chelators are potentially toxic (6) and
often fail to remove lead from all body tissues (7).
Moreover, because they are hydrophilic or lipophobic
(8, 9), they cannot cross the cell membrane to capture
intracellular lead. Thus, drugs with lipophilic properties
are needed.
Recent trends in controlling and treating diseases favor
natural antioxidants. The human diet, which contains
many natural compounds, is essential in protecting the
body against the development of diseases, and garlic
(Allium sativum Linn.) has a broad spectrum of activities:
antibacterial, anticarcinogenic, hypolipidemic, hypogly-
cemic, antifungal, antiatherosclerotic, and antioxidant
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use is cost effective and so it is suitable for economically
disadvantaged people or societies. The antioxidant activ-
ity of garlic is attributed to biologically active lipophilic
sulfur-bearing compounds such as allicin, S-allyl-cysteine
(SAC), diallyl-di-sul?de (DADS), and diallyl-sul?de
(DAS). Processed garlic preparations typically contain
different sulfur compounds. One can expect that the
composition of processed garlic products depend on the
processing method.
This study was conducted to determine if different
garlic extracts (aqueous garlic extract (AGE) and etha-
nolic garlic extract (EGE)) can ameliorate hepatotoxicity
induced in Swiss male albino mice by lead nitrate.
Material and methods
Plant material
The garlic plant (A. sativum) was obtained from the
University medicinal plant garden, Banasthali, India. A
botanist at our department identified it as a local variety.
Preparation of garlic extracts
Aqueous garlic extract (AGE)
Peeled garlic cloves (5 g) were crushed mechanically in a
mortarpestle for 1 min with 10 ml distilled water. The
crushed material was decanted by pressing through
cheese cloth (yield was 500 mg/ml). The extract was
freshly prepared for the experiment whenever needed.
Ethanolic garlic extract (EGE)
The powered garlic bulbs (100 g) were extracted with
ethanol (600 ml) in a Soxhlet extractor for 48 h at 608C.
After extraction, the solvent was evaporated to dryness at
50558C by using a rotary evaporator and the solid
extract (yield was 7.1 g/kg) was stored at 48C. It was
dissolved in distilled water whenever needed for experi-
ments.
Chemicals
Lead nitrate was purchased from Central Drug House
(India). All other chemicals were of analytical grade and
obtained from Sisco Research Laboratories (India),
Qualigens (India/Germany), SD Fine Chemicals (India),
HIMEDIA (India), and Central Drug House (India).
Animals
Male Swiss albino mice weighing 1530 g (22.5 months)
were obtained from Haryana Agricultural University,
Hissar, India. The Animal Ethics Committee of
Banasthali University, Banasthali, India approved the
study. All experiments were conducted on adult male
albino mice when they weighed 2535 g (34 months old).
They were housed in polypropylene cages in an
air-conditioned room at 25938C, relative humidity of
5095% and 12-h alternating light and dark cycles. The
mice were provided with chow diet (Hindustan Lever
Limited, India) and drinking water ad libitum.
Experimental design
The mice were divided into six groups of 12 mice each.
Mice receiving lead nitrate were given 50 mg/kg body
weight lead nitrate: 1.25 mg lead nitrate dissolved in 1 ml
distilled water and given by gavage. This dose is
equivalent to 1/45 of LD50 (11). The doses of garlic
extracts were decided on the basis of experiments
conducted in our own laboratory and on other published
report (12).
Group 1 received 1 ml distilled water by oral gavage
(control group).
Group 2 received lead nitrate daily for 40 days.
Groups 3 and 4 were given AGE 250 mg/kg body
weight or 500 mg/kg body weight by oral gavage once
daily for 30 days starting 11 days after the start of lead
nitrate treatment until the end of the experiment.
Groups 5 and 6 were given EGE at 100 mg/kg body
weight or 250 mg/kg body weight by oral gavage once
daily for 30 days starting 11 days after the start of lead
nitrate treatment until the end of the experiment.
After administration of the last dose, the animals were
given a rest overnight and the following day they were
killed under light ether anesthesia. Livers were removed
immediately, weighed, rinsed in ice-cold saline, blotted,
and used for various biochemical assays, histological
studies, and determination of lead concentration.
Half of each liver was processed for biochemical
analysis and histological examination, and the other
half was stored at 208C before wet acid digestion
with HNO3 for lead estimation.
Biochemical assays
Liver was minced and homogenized (10% w/v) in ice-cold
0.1 M sodium phosphate buffer (pH 7.4). The homo-
genate was centrifuged at 10,000 rpm for 1520 min at
48C twice to get the enzyme fraction. The supernatant
was used for biochemical assays.
Lipid peroxidation (LPO)
LPO was estimated colorimetrically by measuring mal-
ondialdehyde (MDA) formation as described by Nwanjo
and Ojiako (13). In brief, 0.1 ml of homogenate was
treated with 2 ml of a 1:1:1 ratio of TBATCAHCl
(TBA 0.37%, TCA 15%, HCl 0.25 N) and placed in water
bath at 658C for 15 min, cooled, and centrifuged at 5,000
rpm for 10 min at room temperature. The optical density
of the clear supernatant was measured at 535 nm against
a reference blank. The MDA formed was calculated by
using the molar extinction coefficient of thiobarbituric
acid reactants (TBARS; 1.5610
5 l/mole cm
1). The
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Superoxide dismutase (SOD)
Hepatic SOD activity was assayed according to the
method of Marklund and Marklund (14). For the
control, 0.1 ml of 20 mM pyrogallol solution was added
to 2.9 ml of Tris buffer and mixed, and reading was taken
at 420 nm after 1.5 and 3.5 mins. The absorbance
difference for 2 min was recorded and the concentration
of pyrogallol was adjusted in such a way that the rate in
change of absorbance per 2 min was approximately
0.0200.023 optical density units.
Liver extract (200 ml) was treated with 10 ml of 25%
triton X-100 and kept at 48C for 30 min. To 2.8 ml of Tris
buffer, 0.1 ml of treated sample was added and mixed,
and the reaction was started by adding 0.1 ml of adjusted
pyrogallol solution (as for control). Reading was taken at
420 nm after 1.5 and 3.5 mins and the difference in
absorbance was recorded. The enzyme activity was
expressed as U/ml of liver extract and 1 U of enzyme is
defined as the enzyme activity that inhibits auto-oxida-
tion of pyrogallol by 50%.
Catalase (CAT)
Catalase (CAT) activity was estimated following the
method of Aebi (15). Liver extract (100 ml) was treated
with ethanol (10 ml) and placed on an ice bath for 30 min.
To this, 10 ml of 25% triton X-100 was added and again
kept for 30 min on ice. To 200 ml phosphate buffer (0.1
M), 50 ml of treated liver extract and 250 ml of 0.066 M
H2O2 (prepared in 0.1 M phosphate buffer, pH 7.0) were
added in a cuvette. The decrease in optical density was
measured at 240 nm for 60 s. The molar extinction
coefficient of 43.6 cm
1 was used to determine CAT
activity. One unit of activity is equal to the moles of H2O2
degraded/min/mg protein.
Glutathione (GSH)
Reduced glutathione (GSH) was determined by the
method of Ellman (16). In brief, 1 ml of supernatant
was taken after precipitating 0.5 ml of liver homogenate
with 2 ml of 5% TCA. To this, 0.5 ml of Ellman’s reagent
(0.0198% DTNB in 1% sodium citrate) and 3 ml of
phosphate buffer (1 M, pH 8.0) was added. The color
developed was read at 412 nm. Reduced GSH concentra-
tion is measured by using a drawn standard curve and
was expressed as mg/g of tissue.
Aspartate aminotransferase (AST) and alanine
aminotransferase (ALT)
Activities of aspartate aminotransferase (AST) and
alanine aminotransferase (ALT) were assayed by the
method of Reitman and Frankel (17). In brief, 0.2 ml
of liver fraction and 0.5 ml of substrate solution (for
AST: aspartate and 2-ketoglutarate; for ALT: alanine and
2-ketoglutarate) were incubated at 378C for 60 min for
AST and 30 min for ALT. After incubation, 0.5 ml of
DNPH solution was added to arrest the reaction, which
was kept for 20 min at room temperature. To this, 1 ml of
0.4 N NaOH was added and absorbance was read at 510
nm. Activities were expressed as IU/L.
Acid phosphatase (ACP) and alkaline phosphatase
(ALP)
Activities of acid phosphatase (ACP) and alkaline
phosphatase (ALP) were determined according to the
protocol described in a laboratory practical manual (18).
Substrate solution (3 ml) was incubated at 378C for 15
min and then 0.5 ml liver homogenate was added. It was
mixed well and immediately 0.05 ml of the mixture was
removed and mixed with 9.5 ml of 0.085 N NaOH. This
corresponded to zero time assay (blank). The remaining
solution (substrateenzyme) was incubated for 15 min at
378C and then 0.5 ml was drawn and mixedwith 9.5 ml of
0.085 N NaOH. Absorbance was measured at 405 nm
against the reference blank. Specific activities were
expressed as mmoles of p-nitrophenol formed per min
per g tissue.
Protein
Protein content was determined by the method of Lowry
et al. (19) and bovine serum albumin as a standard.
Cholesterol
Cholesterol was determined by the method of Zak (20)
with cholesterol as a standard.
Lead nitrate
The accurately measured samples of liver (250 mg) were
digested in 10 ml concentrated HNO3 by using Micro-
wave Digestion System. After evaporation of HNO3,
dried samples were dissolved in 10 ml of distilled water.
Lead content was estimated using a Hydride Vapour
Generation System (Model MHS-10, Perkin Elmer) fitted
with a Flame Atomic Absorption Spectrometer (AAS,
Perkin Elmer model A Analyst 100, Uberlingen, Ger-
many) against suitable standards processed identically.
Histological studies
Liver was dissected from the animals and fixed in
buffered 10% formalin at room temperature for 72 h. It
was then thoroughly washed under running water and
dehydrated in ascending grades of ethyl alcohol, cleared,
and embedded in soft paraffin. Tissue sections of about 6
mm were cut, stained with hematoxylin and eosin, and
examined with a light microscope.
Allium sativum ameliorates lead-induced hepatotoxicity
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Data are expressed as the mean9SEM. The data were
analyzed by analysis of variance (ANOVA) followed by
Tukey test using the Statistical Package for the Social
Sciences (S.P.S.S. 11). The level of significance was set at
pB0.05.
Results
Table 1 shows the activity of TBARS and antioxidant-
related parameters in liver. Lead nitrate exposure was
detrimental to the redox status of liver, as evidenced by a
significant rise (pB0.001) in LPO level (61.0%) and
significant depletion in CAT activity (55.7%), SOD
activity (34.5%), and GSH content (78.9%) in mice
treated with lead nitrate but no garlic extract (Group 2)
compared with untreated animals.
Compared to Group 2 (only PbNO3), Groups 3 and 4
showed a marked decrease in LPO level (17.9 and 25.9%)
and a marked increase in CAT level (30.3 and 89.9%),
and GSH content (157.6 and 278.8%) (pB0.001). In
Group 4, there was a significant increase (31.08%; pB
0.01) in the activity of SOD compared to Group 2, but
SOD activity in Group 3 did not differ significantly from
Group 2.
In Groups 5 and 6, the percent decrease (pB0.001) in
hepatic LPO level was 20.5% and 33.1%, respectively, as
compared with lead nitrate control values (Group 2).
CAT (36.1 and 104.1%) and GSH (150.6 and 313.4%)
activities were raised significantly (pB0.001) in Groups 5
and 6, respectively, when compared with lead nitrate-
administered mice (Group 2), but no significant differ-
ence in SOD activity was observed in both Groups 5 and
6 treated animals.
Table 1 shows the lead accumulation pattern in the
liver of different experimental groups. Administration of
lead nitrate to Group 2 significantly increased (pB0.001)
the level of lead nitrate in liver (3.8490.28 mg/g wet tissue
vs. 0.05390.007 mg/g wet tissue in the negative control
group).
In Groups 3 and 4, lead nitrate content reduced
significantly (pB0.001) (38.02% and 70.31%, respec-
tively), in comparison to Group 2. Hepatic lead nitrate
content decreased significantly in Groups 5 and 6
(38.54% and 67.18%, pB0.001, respectively), when
compared with Group 2.
Exposure to lead nitrate (50 mg/kg body weight) alone
induced a significant augmentation (pB0.001) in AST
(56.3%), ALT (105.9%), ACP (196.8%), ALP (170.9%),
and total cholesterol (131.4%) levels, as compared to
control animals. However, lead nitrate administration
significantly decreased (pB0.001) total protein content
(39.7%) in the liver when compared with the control
group.
Compared to Group 2, which received only lead nitrate,
Groups 3 and 4 showed significant declines (pB0.001) in T a b l e
1
.
P
r
o
t
e
c
t
i
v
e
e
f
f
e
c
t
o
f
g
a
r
l
i
c
e
x
t
r
a
c
t
s
o
n
h
e
p
a
t
i
c
o
x
i
d
a
t
i
v
e
s
t
r
e
s
s
-
r
e
l
a
t
e
d
p
a
r
a
m
e
t
e
r
s
a
n
d
l
e
a
d
l
e
v
e
l
i
n
l
e
a
d
n
i
t
r
a
t
e
-
e
x
p
o
s
e
d
m
i
c
e
C
o
n
t
r
o
l
g
r
o
u
p
T
r
e
a
t
e
d
m
o
u
s
e
g
r
o
u
p
s
P
a
r
a
m
e
t
e
r
G
r
o
u
p
1
G
r
o
u
p
2
G
r
o
u
p
3
G
r
o
u
p
4
G
r
o
u
p
5
G
r
o
u
p
6
L
P
O
1
1
0
.
0
7
9
1
.
3
7
1
7
7
.
2
9
9
1
.
9
8
*
(

6
1
.
0
%
)
1
4
5
.
4
2
9
1
.
5
6
a
(

1
7
.
9
%
)
1
3
1
.
3
7
9
2
.
0
4
a
(

2
5
.
9
%
)
1
4
0
.
7
7
9
1
.
1
7
a
(

2
0
.
5
%
)
1
1
8
.
5
9
1
.
8
6
a
(

3
3
.
1
%
)
S
O
D
1
.
1
3
9
0
.
0
3
0
.
7
4
9
0
.
1
0
*
(

3
4
.
5
%
)
0
.
8
3
9
0
.
0
1
(

1
2
.
1
%
)
0
.
9
7
9
0
.
0
2
b
(

3
1
.
0
8
%
)
0
.
7
9
9
0
.
0
1
(

6
.
7
%
)
0
.
8
7
9
0
.
0
1
(

1
7
.
5
%
)
C
A
T
7
8
.
9
2
9
1
.
0
8
3
4
.
9
6
9
0
.
7
3
*
(

5
5
.
7
%
)
4
5
.
0
4
9
0
.
9
8
a
(

3
0
.
3
%
)
6
5
.
6
5
9
1
.
0
4
a
(

8
9
.
9
%
)
4
7
.
0
4
9
0
.
9
4
a
(

3
6
.
1
%
)
7
0
.
5
5
9
1
.
1
1
a
(

1
0
4
.
1
%
)
G
S
H
7
.
4
1
9
0
.
0
8
1
.
5
6
9
0
.
1
2
*
(

7
8
.
9
%
)
4
.
0
2
9
0
.
0
5
a
(

1
5
7
.
6
%
)
5
.
9
1
9
0
.
0
6
a
(

2
7
8
.
8
%
)
3
.
9
1
9
0
.
0
6
a
(

1
5
0
.
6
%
)
6
.
4
5
9
0
.
1
4
a
(

3
1
3
.
4
%
)
L
e
a
d
l
e
v
e
l
0
.
0
5
3
9
0
.
0
0
7
3
.
8
4
9
0
.
2
8
*
(

7
1
4
5
.
2
%
)
2
.
3
8
9
0
.
2
1
a
(

3
8
.
0
%
)
1
.
1
4
9
0
.
1
9
a
(

7
0
.
3
%
)
2
.
3
6
9
0
.
3
2
a
(

3
5
.
5
%
)
1
.
2
6
9
0
.
3
8
a
(

6
7
.
1
8
%
)
N
o
t
e
:
L
P
O
,
l
i
p
i
d
p
e
r
o
x
i
d
a
t
i
o
n
(
M
a
l
o
n
d
i
a
l
d
e
h
y
d
e
f
o
r
m
e
d
i
n
n
m
o
l
e
/
g
m
)
;
S
O
D
,
s
u
p
e
r
o
x
i
d
e
d
i
s
m
u
t
a
s
e
(
U
/
m
l
o
f
t
i
s
s
u
e
e
x
t
r
a
c
t
)
;
C
A
T
,
c
a
t
a
l
a
s
e
(
m
m
o
l
e
s
o
f
H
2
O
2
d
e
g
r
a
d
e
d
p
e
r
m
i
n
p
e
r
m
g
p
r
o
t
e
i
n
)
;
G
S
H
,
r
e
d
u
c
e
d
g
l
u
t
a
t
h
i
o
n
e
(
m
g
/
g
t
i
s
s
u
e
)
;
l
e
a
d
,
(
m
g
/
g
m
w
e
t
t
i
s
s
u
e
)
.
V
a
l
u
e
s
a
r
e
m
e
a
n
9
S
E
M
,
n

1
2
.
*
p
B
0
.
0
0
1
c
o
m
p
a
r
e
d
t
o
n
o
r
m
a
l
a
n
i
m
a
l
s
.
a
p
B
0
.
0
0
1
c
o
m
p
a
r
e
d
t
o
l
e
a
d
n
i
t
r
a
t
e
-
e
x
p
o
s
e
d
a
n
i
m
a
l
s
.
b
p
B
0
.
0
1
c
o
m
p
a
r
e
d
t
o
l
e
a
d
n
i
t
r
a
t
e
-
e
x
p
o
s
e
d
a
n
i
m
a
l
s
.
Arti Sharma et al.
4
(page number not for citation purpose)
Citation: Libyan J Med 2010, 5: 4621 - DOI: 10.4176/091107the levels of AST (15.3% and 27.0%, respectively), ALT
(31.8 and 38.6%), ACP (23.3 and 51.7%), ALP (25.9 and
34.5%), and total cholesterol (20.7 and 50.3%) accom-
panied by a significant increase (pB0.001) in total
protein content (31.6 and 55.1%).
Compared to mice receiving only lead nitrate (Group
2), administration of EGE in Groups 5 and 6 significantly
(pB0.001) reduced the augmentation of AST (by 17.4
and 29.0%), ALT (by 23.2 and 41.0%), ACP (by 34.9 and
56.1%), ALP (by 31.8 and 44.5%), and total cholesterol
(by 33.6 and 43.9%). On the other hand, protein content
in liver was significantly increased by 23.5% (pB0.02)
and 49.4% (pB0.001), in Groups 5 and 6, respectively
(Table 2).
Histological results
The liver of control mice showed normal hexagonadal or
pentagonadal lobules with central veins and peripheral
hepatic triads or tetrads embedded in connective tissue.
Hepatocytes are arranged in trabecules running radially
from the central vein and are separated by sinusoids
containing Kupffer cells. They are regular and contain a
large spheroidal nucleus (Fig. 1).
The livers of mice exposed to lead nitrate for 40 days
revealed disruption of the normal structural organization
of the hepatic lobules and loss of the characteristic cord-
like arrangement of the normal liver cells. The central
and portal veins were congested. Many hepatic cells were
damaged and lost their characteristic appearance while
others showed marked cytoplasmic vacuolization. The
nuclei of these cells were pyknotic. The central vein and
sinusoids between hepatocytes were dilated. Some leuko-
cyte infiltration and fatty deposition were also evident
(Fig. 2).
Animals treated with low doses of aqueous and EGEs
(Groups 3 and 5) showed that the majority of these
histopathological changes were diminished but some
hepatocytes appeared with vacuolized cytoplasm and
the central vein appeared congested (Fig. 3).
In the high dose groups (Groups 4 and 6), the liver
restored most of its normal structure and was able to
diminish the fibrosis, congestion, incidence of inflamma-
tory cells infiltration, centrilobular hepatocytes swelling,
hepatocytes vacuolization, fatty changes, and hemorrha-
gic clots (Fig. 4).
Discussion
Lead is a wide spread constituent of earth’s crust (21). It
can cause hypertension, developmental defects, neurolo-
gical problems, renal dysfunction, and anemia. In recent
years dietary plants with antioxidant property have been
receiving considerable attention. It is believed that these
plants can protect tissues against the damaging effect of
free radicals (22). The role played by natural compounds
in the modulation of the toxic effects of lead nitrate is T a b l e
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Lead nitrate
Our results indicate a significant alternation in the
peroxidative process following lead nitrate exposure.
The increase in LPO level and decrease in the endogenous
antioxidant enzymes SOD, CAT, and GSH by lead
nitrate (Table 1) are consistent with earlier reports (23,
24).
Cellular systems are well protected from ROS-induced
cell injuries by an array of defenses composed of various
antioxidants with different functions. Whenever the ROS
present in the cellular system overpower these defense
systems, they cause oxidative stress or cell injury, leading
to the development of diseases. It has been revealed that
lead toxicity leads to free radical damage via two separate
pathways: (1) the generation of ROS, including hydro-
peroxides, singlet oxygen, and hydrogen peroxide and (2)
the direct depletion of antioxidant reserves (25).
The cell membrane is the main target of the oxidative
damage produced by xenobiotics, including heavy metals
(26). This is mainly due to changes in polyunsaturated
fatty acids having double bonds, largely present in the
phospholipids of membranes (27). Lead is known to
produce oxidative damage by enhancing peroxidation of
membrane lipids, and LPO is a deleterious process
carried out solely by free radicals. In fact, LPO is an
outcome of the chain of events involving initiation,
propagation, and termination reactions (28). Unchecked
peroxidative decomposition of membrane lipids is cata-
strophic for living systems. The lipid peroxides produced
are degraded into a variety of products, including
alkanals, hydroxyl alkanals, ketones, and alkenes (26).
Fig. 1. Transverse section of the liver of a control mouse
showing hepatic cords arranged radially around the central
vein and normal hepatocytes with centrally located nuclei.
Fig. 2. Transverse section of the liver of a mouse treatedwith
lead nitrate showing congestion of central vein, vacuoliza-
tion, leucocytic inﬁltration, pyknotic nuclei, and loss of
radial arrangement of hepatocytes.
Fig. 3. Liver section obtained from a mouse treated with
lead nitrate followed by a low dose of garlic extract. Normal
arrangement of hepatocytes is restored but a central vein is
congested.
Fig. 4. Liver section obtained from a mouse after treatment
with lead nitrate and garlic showing improvement of hepatic
tissue.
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tion or cause oxidative stress by undergoing radical chain
reactions ultimately leading to loss of membrane integ-
rity. LPO can also adversely affect the function of
membrane-bound proteins, such as enzymes and recep-
tors. Several studies have focused on the possible toxic
effects of lead on membrane components and identified a
correlation between these effects and lead-induced oxida-
tive damage. Yiin and Lin (29) demonstrated a marked
enhancement in MDA concentration following incuba-
tion of linoic, linolenic, and arachidonic acid with lead.
According to Caylak et al. (30), lead might have a direct
peroxidative activity or act indirectly by providing con-
ditions suitable for LPO. Direct peroxidative activity of
lead may be associated with ROS generation, such as
H2O2, atomic oxygen, and hydroxyl radicals (31).
Usually, the deleterious effects of oxidative stress are
counteracted by endogenous antioxidant enzymes,
mainly SOD, CAT, and GSH (32).
In the present study, the activities of SOD, CAT, and
GSH antioxidants were reduced by lead nitrate, thus
exposing the tissues to peroxidative damage. CAT and
SOD are metalloproteins accomplishing their antioxidant
functions by enzymatically detoxifying peroxides
(
OOH), H2O2, and O2. These antioxidant enzymes
depend on various essential trace elements and prosthetic
groups for proper molecular structure and enzymatic
activity. The pathogenesis of lead toxicity is multifactor-
ial, as lead directly interrupts enzyme activation, compe-
titively inhibits trace mineral absorption, and binds to
sulfhydryl proteins (interrupting structural protein synth-
esis) (27).
New findings revealed that GSH depletion is another
important mechanism of lead toxicity. GSH is a tripep-
tide-containing cysteine with a reactive SH group and
reductive potency. GSH is an important cellular antiox-
idant defense system against free radical overproduction,
and decreasing its cellular concentration impairs cellular
defenses against oxidative stress (33). It can act as a non-
enzymatic antioxidant by direct interaction of the SH
group with ROS, or it can be involved in the enzymatic
detoxification reactions for ROS as a cofactor or a
coenzyme (34). It possesses carboxylic acid groups, an
amino group, a SH group, and two peptide linkages as
sites for reactions of metals. Lead binds exclusively to the
SH group, which decreases the GSH levels and can
interfere with the antioxidant activity of GSH (4).
Liver enzymes such as AST, ALT, ACP, and ALP are
marker enzymes for liver function and integrity (35).
These enzymes are usually elevated in acute hepatotoxi-
city or mild hepato-cellular injury, but tend to decrease
with prolonged intoxication due to liver damage (36). In
our study, administration of lead nitrate led to a
significant rise in total cholesterol level, AST, ALT,
ACP, and ALP activities, and conversely decreased total
protein level (Table 2). These results are in accordance
with our previous findings (37).
The increased levels of AST and ALT have been
attributed to the damaged structural integrity of the liver.
Lead causes cell lysis by affecting the K
Ca
2 chan-
nels. Cytoskeleton alterations induce increased suscept-
ibility to lysis (38).
Administration of lead nitrate also causes assimilation
of fat in the liver, leading to increased ACP activity. This
may be also due to the lysosomal imbalance resulting in
the destruction of the intact membranes (39). ALP has
been reported to be the marker enzyme for plasma
membrane (40) and is required in certain amounts for
proper functioning of organs (41). Increase in the ACP
and ALP activities indicated the increased permeability,
damage, and/or necrosis of cells.
In our study, decrease in total protein levels was
observed in liver tissue, which is in agreement with El-
Zayat et al. (42), who found a decrease in hepatic total
protein content in response to lead intoxication. The
inhibitory role of lead in protein synthesis may be due to
its damaging effect on DNA and RNA (43). Lead is
associated with DNA damage through base pair muta-
tion, deletion, or oxygen radical attack on DNA. More-
over, Pb
2 disturbs intracellular Ca
2 homeostasis (44)
and damages the endoplasmic reticulum, which in turn
results in reduction of protein synthesis.
In the present work, lead nitrate intake increased the
mean values of cholesterol significantly in liver tissue. In
agreement with our data, other workers also demon-
strated that lead intake is associated with significant
increase in plasma cholesterol (45). It was found that
administration of lead to rats elevated plasma low-
density lipoprotein (LDL) and reduced plasma high-
density lipoprotein (HDL) (46). Lead nitrate-mediated
development of hypercholesterolemia involves the activa-
tion of cholesterol biosynthetic enzymes (i.e. 3-hydroxy-
3methyglutaryl-CoA reductase, farnesyl diphosphate
synthase, and squalene synthase, CYP51) and the simul-
taneous suppression of cholesterol-catabolic enzymes
such as 7a-hydroxylase (47).
We observed that lead exposure produced pronounced
hepatic histopathology evidenced by histological alterna-
tions in liver, including focal necrosis with hepatocyte
vacuolization and swelling, pyknotic nuclei, and dilation
of central vein and sinusoids. These findings are in
support with Shalan et al. (43). In accordance with our
findings, El Sokkary et al. (48) also showed that liver of
lead-treated rats revealed remarkable degenerative altera-
tions. Lead hepatotoxicity led to vacuolization of the
cells, polymorphism of the nuclei, and decrease in
glycogen content of the hepatocytes (49, 50).
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Garlic and garlic extracts, used for millennia in folk
medicine, are reported to provide protection against free
radical damage in the body through their antioxidant
activities (51). The role of garlic organosulfur compounds
in free radical scavenging has been investigated by
numerous investigations. Allicin is a major component
of garlic organosulfurs and its antioxidant properties has
already been confirmed. In addition to allicin, other
garlic organosulfurs, such as alliin, allyl cysteine, allyl
disulfide, and diallyl disulfide, possess antioxidant prop-
erties and can neutralize several types of ROS (52). The
consequence of synergism between various compounds is
responsible for the antioxidant activity of garlic. The
chemical reactions of garlic principles may be represented
as follows:
NADPH + H+ + R – S – S – R
NADP+ + 2RSH 
RSH + OH• RS• + H2O
2RS• R – S – S – R 
Garlic extract was found to scavenge hydroxyl radical
(53), superoxide anion (53), and modulate LPO (54).
We observed that administration of A. sativum partly
restored the altered levels of SOD, CAT, and GSH
antioxidant molecules, which confirmed that garlic con-
tains antioxidant compounds and protects tissues against
lead nitrate-induced oxidative stress. Thiols (SH-group)
are thought to play a pivotal role in protecting cells
against ROS (55). Augmentation of GSH and its related
enzymes is a major mechanism of garlic organosulfur
hepatoprotection.
We also found that levels of liver marker enzymes
(AST, ALT, ACP, and ALP) were decreased significantly
by treatment with A. sativum extract. The observed
decrease in these enzymes showed that garlic preserves
the structural integrity of the tissues from the toxic effect
of lead nitrate. Organosulfur components (as diallyl
sulfide) present in garlic exhibit protective effects against
toxicants (56).
Total restoration of protein levels in liver of mice
treated with A. sativum extract indicated the ability of
garlic extracts to stimulate the regeneration of tissues. It
increased protein synthesis in damaged tissues and led to
improvement in the functional status of the cells.
A. sativum treatment decreased total cholesterol level
in liver. The mechanism of action was first suggested by
Sodimu et al. (57), who indicated that garlic prevented an
increase of cholesterol, triglyceride, and total lipids by
inactivation of thiol group enzymes such as HMG-CoA
reductase and CoASH, the rate-limiting enzyme for
cholesterol biosynthesis, and the multi-enzyme complex
for fatty acid biosynthesis.
Results from the present investigation also revealed
that the use of garlic extracts along with lead nitrate can
reduce lead accumulation in tissue. Sulfur-containing
amino acids such as cysteine have already been reported
for their chemoprophylactic use in lead toxicosis (58).
The efficiency of garlic was perhaps due to the presence
of these sulfur-containing amino acids and compounds
having free carboxyl (CO) and amino (NH2) groups in
their structures. These biologically active compounds
might have chelated lead and enhanced its excretion
from the body, resulting in reduced lead accumulation in
tissues. The mechanism of A. sativum-mediated chelation
of lead nitrate might include formation of ionic bonds
between sulfur-containing compounds and lead. Garlic
components with sulfur moieties have been documented
to act as active Lewis acids with electron affinity and
therefore have a tendency to form compounds with
positively charged ions (59). In contrast, lead is a highly
electropositive metalloid exhibiting ionic states of 2
and is an active Lewis base. It thus possesses an affinity
for negative ions and forms stable compounds with them.
In the reaction, major organosulfur compounds, which
act as oxidants (e.g. allicin and SAC) (60) are probably
reduced.
Pb
2 acts as Lewis base and highly electropositive
SH group of major thiosulfinates of garlic acts as
Lewis acid due to their high electronegativity and
electron affinity
Chelation of lead
Moreover, garlic also contains biologically active lipo-
philic sulfur-bearing compounds such as allicin, SAC,
DADS, and DAS, and these compounds can easily
permeate through phospholipid membranes (61) and
reduce intracellular lead. This can explain the consider-
able reduction of hepatic lead burden following admin-
istration of A. sativum. Our study confirms earlier reports
suggesting that garlic can reduce lead in some tissues in
mice (62).
A. sativum extracts at both dose levels produced
protective effects on histological structure of the liver
against lead toxicity. When garlic extracts were adminis-
tered with lead, the liver retained its normal architecture
and was also able to diminish fibrosis, congestion, and
hepatocyte vacuolation. These results are in accordance
with Banerjee et al. (12) to some extent.
Conclusion
We show that garlic treatment partly mitigates lead
nitrate-induced changes in hepato-chemical parameters.
This could be due to its antioxidant nature, which
combines free radical scavenging with metal chelating
properties. The healing effect of garlic was also confirmed
by histological observations, which suggest that the garlic
Arti Sharma et al.
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provement of hepatocytes.
Garlic can be given as a dietary supplement to human
populations exposed to environmental toxicants and can
provide protection against toxic effects without being
appreciably harmful itself. Moreover, efforts are needed
for the choice of appropriate dose, duration of treatment,
and possible side-effects on major organs.
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